Total Funding
53
64
Total FundingSeries A raised
Growth Score
-1 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
30279
Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.
- Nicolas Tilmans: CEOPast Role: Lumiata, VP Engineering
- Adrian Schreyer: Chief Technology OfficerPast Role: Exscientia, Head of Molecular Informatics
About the Company
Anagenex is a seed stage biotechnology company building a novel platform for drug discovery focusing on difficult targets.
